Pivotal Therapeutics Inc. announced earnings results for the three months ended September 30, 2014. For the quarter, the company reported a loss of CAD 1,632,052 or CAD 0.02 per common share. This included CAD 97,200 in non-cash stock option expenses, CAD 156,145 in interest on long-term debt and CAD 378,018 in accretion expense.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0018 USD | +179,900.00% | -.--% | -.--% |
2016 | Pivotal Therapeutics Inc. Announces Management Changes | CI |
2015 | Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 172K | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.63B |
- Stock Market
- Equities
- PVTTF Stock
- News Pivotal Therapeutics Inc.
- Pivotal Therapeutics Inc. Announces Earnings Results for the Three Months Ended September 30, 2014